Impact of the Recent Mouse P-Glycoprotein Structure for Structure-Based Ligand Design

被引:28
作者
Klepsch, Freya [1 ]
Ecker, Gerhard F. [1 ]
机构
[1] Univ Vienna, Dept Med Chem, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
Proteins; Molecular modelling; Drug design; Ligands; HUMAN MULTIDRUG TRANSPORTER; MEDIATED DRUG TRANSPORT; DISULFIDE CROSS-LINKING; RETRACTED ARTICLE. SEE; ATP-BINDING; MOLECULAR-BASIS; TRANSMEMBRANE DOMAINS; CALCIUM-ANTAGONISTS; CLOSED CONFORMATION; RESISTANCE PROTEIN;
D O I
10.1002/minf.201000017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
P-Glycoprotein (P-gp), a transmembrane, ATP-dependent drug efflux transporter, has attracted considerable interest both with respect to its role in tumour cell multidrug resistance and in absorption-distribution and elimination of drugs. Although known since more than 30 years, the understanding of the molecular basis of drug/transporter interaction is still limited, which is mainly due to the lack of structural information available. However, within the past decade X-ray structures of several bacterial homologues as well as very recently also of mouse P-gp have become available. Within this review we give an overview on the current status of structural information available and on its impact for structure-based drug design.
引用
收藏
页码:276 / 286
页数:11
相关论文
共 98 条
[1]   P-glycoprotein senses its substrates and the lateral membrane packing density:: Consequences for the catalytic cycle [J].
Aanismaa, Paivi ;
Gatlik-Landwojtowicz, Ewa ;
Seelig, Anna .
BIOCHEMISTRY, 2008, 47 (38) :10197-10207
[2]   Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding [J].
Aller, Stephen G. ;
Yu, Jodie ;
Ward, Andrew ;
Weng, Yue ;
Chittaboina, Srinivas ;
Zhuo, Rupeng ;
Harrell, Patina M. ;
Trinh, Yenphuong T. ;
Zhang, Qinghai ;
Urbatsch, Ina L. ;
Chang, Geoffrey .
SCIENCE, 2009, 323 (5922) :1718-1722
[3]  
Allikmets R, 1998, CANCER RES, V58, P5337
[4]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[5]   Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoprotein [J].
Bachmakov, I ;
Rekersbrink, S ;
Hofmann, U ;
Eichelbaum, M ;
Fromm, MF .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 (03) :195-201
[6]   Membrane topology and glycosylation of the human multidrug resistance-associated protein [J].
Bakos, E ;
Hegedus, T ;
Hollo, Z ;
Welker, E ;
Tusnady, GE ;
Zaman, GJR ;
Flens, MJ ;
Varadi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12322-12326
[7]   Molecular models of human P-glycoprotein in two different catalytic states [J].
Becker, Jean-Paul ;
Depret, Gregoire ;
Van Bambeke, Francoise ;
Tulkens, Paul M. ;
Prevost, Martine .
BMC STRUCTURAL BIOLOGY, 2009, 9
[8]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[9]   New physiological functions for drug-transporting P-glycoproteins? [J].
Borst, P ;
van Blitterswijk, WJ ;
Borst, J ;
Tepper, AD ;
Schinkel, AH .
DRUG RESISTANCE UPDATES, 1998, 1 (05) :337-339
[10]   Transporter-Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target [J].
Broccatelli, Fabio ;
Carosati, Emanuele ;
Cruciani, Gabriele ;
Oprea, Tudor I. .
MOLECULAR INFORMATICS, 2010, 29 (1-2) :16-26